Invasive aspergillosis in an immunocompetent host is a rare clinical entity. The purpose of this article is to create awareness of existence of invasive sino-orbital aspergillosis in an immunocompetent, young, otherwise healthy host and its management with emphasizing the importance of balancing open surgical approach with endoscopic approach in order to achieve the optimum clearance of disease. A 48 years old female patient presented with 6 months history of nontender swelling over the left maxilla, 5 months history of left-sided nasal blockage and 2 months history of left orbital proptosis.
INTRODUCTION
A 48 years old female patient presented with history of nontender swelling over left maxillary region, spontaneous in onset rapidly growing in size since 6 months, followed by history of left-sided nasal blockage, rapidly worsened since 5 months which was followed by history of left orbital proptosis mimicking that of sinonasal malignancy. There was history of numbness over left cheek and upper lip. There was no history suggestive of allergic rhinitis. There was no history suggestive of diminution of vision, blurring of vision, recurrent headache, vomiting, altered sensorium and convulsion. Patient was nondiabetic, immunocompetent and so far had not received topical or systemic steroids.
On examination there was ill-defined approximately 4 × 5 cm diffuse fullness over the left maxillary region and left orbital proptosis. There was loss of sensation over distribution of left maxillary division of trigeminal nerve. However patient's vision, extraocular movements were not affected and fundoscopy revealed no abnormality ( Figs 1A and B) . Diagnostic nasal endoscopy revealed polyps and tenacious secretions in bilateral nasal cavity (Fig. 1C) . Polyps were pale in color, insensitive to and did not bleed on touch. CT scan PNS revealed lobulated hyperdense partially enhancing soft tissue with areas of bone scalloping, thinning and erosion involving the medial wall of orbit, anterior, posterior and medial wall of left maxillary sinus and left ethmoid lamellae extending upto clivus with proptosis of left eye ball. However, dura matter was not breeched by mass (Figs 2A and B) . Findings were suggestive of chronic invasive fungal sinusitis (CIFS).
Nasal swab for fungal culture revealed septate, branching, spore forming fungal hyphae consistent with aspergillosis. Biopsy from nasal mass revealed respiratory mucosa with granulomatous inflammation with features consistent that with aspergillosis (Fig. 3) .
Subsequently the patient was worked up for endoscopic debridement of fungal granuloma.
Considering the extensive lesion, the debridement was carried out in two stages. Under cover of antifungal such as injection voriconazole pre-, peri-and postoperatively, endoscopic debridement was done. Careful exploration of all sinuses bilaterally by endoscopic approach was done and thick tenacious material removed which was then sent for histopathological examination. All sinus ostia were opened widely and adequately for easy douching. However, the disease lateral to orbital periosteum was not cleared surgically and orbital periosteum was not breached. Subsequently patient was put on oral voriconazole for 2 weeks.
Histopathology confirmed the diagnosis of fungal granuloma (Figs 4A to C).
MRI orbit, PNS and brain was done 2 weeks after the first stage of debridement revealed a large residual lesion approximately 5.3 × 3.4 cm in maximum transverse dimensions and 6.8 cm in superoinferior extent in left premaxillary soft tissues, extending contiguously into left maxillary sinus, nasal cavity and orbit. The lesion was extending superiorly to erode the floor and medial wall of left orbit infiltrating the extraconal compartment of left orbit resulting in orbital proptosis (Figs 5 and 6 ). Since this lesion could not be approached by endoscopic approach, we approached the lesion by Caldwell-Luc approach in order to clear disease from anterolateral and roof of maxillary sinus. Oral voriconazole continued post debridement. MRI orbits with PNS repeated after 3 weeks revealed substantial clearing of soft tissue lesion seen on previous scan. However, there was approximately 3.4 × 2.2 cm residual lesion within medial extraocular compartment of left orbit with retrobulbar extension (Figs 7 and 8) .
Patient became symptomatically better with significant decrease in orbital proptosis. Here, we decided to continue 
DISCUSSION
Aspergillosis refers to several forms of disease caused by fungus in genus Aspergillus. Aspergillus fungal infections can occur in ear, eyes, nose, PNS and lungs.
1 DeShazo (1998) noted three types of invasive disease: 2,3 acute fulminant fungal sinusitis (AIFS), the CIFS and granulomatous invasive fungal sinusitis. For all practical purposes, the term CIFS is used to describe both granulomatous and nongranulomatous nonfulminant but invasive disease. In granulomatous invasive fungal rhinosinusitis Aspergillus flavus is the commonest pathogen isolated. 3 The CIFS is diagnosed by the clinical presentation and histopathology report. A diagnosis of CIFS is made in patients with a prolonged clinical course (symptoms persisting for more than 4 weeks), radiologic evidence of sinusitis and presence of hyphal forms (septate hyphae) in the tissue. 4 Orbital invasive aspergillosis is rare but often results in fatal Aspergillus sinus mycoses. Invasive aspergillosis can either be localized or fulminant. Localized disease often starts in the sinuses and spreads to adjacent structures through focal bony erosion or even through vessel walls. The fulminant form is characterized by multiple organ involvement. There is no uniformly accepted completely effective treatment for orbital aspergillosis. 4 Management often begins with surgical debridement followed by systemic antifungal drug therapy. Some antifungal drugs described such as polyenes (amphotericin B), azoles (itraconazole, voriconazole) and other newer classes, such as lipid complex nystatin and echinocandins. Of the azole class, itraconazole, voriconazole are safer and easier to administer than amphotericin B.
5
There is no consensus regarding the extent of surgery required for this condition and whether nongranulomatous form should be treated differently from the granulomatous form. 1, 6 It is rational to remove all diseased tissue without violating protective tissue planes, such as periorbita and dura that may act as barriers to further spread of disease and without sacrificing the important structures.
7,8
In this case even after initial stage of endoscopic debridement there was a large residue in left maxillary sinus over anterolateral wall and roof which could not be accessed by endoscope hence we had to use Caldwell-Luc approach to remove the disease. However, there was still a tiny residue in retrobulbar region but patient's proptosis had drastically reduced. Here we had to balance between radical debridement vs functional outcome hence we decided to continue with medical line of management in the form of oral voriconazole 200 mg twice a day for 3 months. Patient had uneventful recovery on 3 months of follow-up. Here we decided to continue oral voriconazole thereafter. Although, MRI scan repeated thereafter showed obliteration of maxillary sinus cavity with no significant change in extent of residual lesion, there was change in lesion morphology suggesting post-treatment changes. Question still remains unanswered as to how long the treatment needs to be continued. Since, lesion seen on imaging does not seem to signify active pathological process as in this case, investigations such as C-reactive protein and ESR remain markers for clinical improvement.
CONCLUSION
Although, invasive sinonasal aspergillosis is more commonly seen in immunocompromised patients, it can occur in young, healthy immunocompetent host. Since, there is no consensus regarding the extent of the surgery required for this condition, each case needs to be assessed individually for appropriate surgical intervention. Although, endoscopic approach is widely recommended the role of open surgical approach should not be underestimated to achieve optimum clearance. Appropriate surgical debridement should be followed by systemic antifungal agents.
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